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Background: Pulmonary embolism is a blood clot that occurs in the lungs, which decreases the
oxygen levels in the body. Large or multiple pulmonary emboli can be fatal. This case involves a
20 year old female soccer player (goalkeeper) who was diagnosed with a pulmonary embolism
during the middle of the regular season. Upon initial assessment, the athlete presented with
soreness and redness over her left distal adductors after getting cleated during practice a few
days earlier. The initial assessment was adductor tendinitis and treated conservatively.
Subsequently, the area became hot, red, and painful and the athlete was removed from practice.
Eventually signs and symptoms resolved and the athlete returned to full participation. Several
weeks later, the athlete presented with right sided chest pain and visited the campus health
center. Differential diagnosis: Musculoskeletal pain, pericarditis, pleuritis. Treatment: The
athlete was referred to the emergency room after blood work was performed. The athlete was
told she could not exercise for at least three months. During this time, she was placed on
anticoagulants. After the season ended, the athlete was told she could no longer play contact
sports after a CT scan revealed pulmonary embolism. Uniqueness: Typically, patients with
pulmonary embolism will present with chest pain, shortness of breath, and hypoxia. In addition,
the incidence of pulmonary embolism is extremely rare in young, healthy athletes with no
significant medical history. Conclusion: Although most patients with pulmonary embolism have
had surgery or are elderly and generally unhealthy, the majority tend to recover. These patients
tend to have recurrent pulmonary emboli in the future after their primary embolism. In a young,
healthy population, factors that increase the risk of developing pulmonary embolism are cancer,
fractures of the hip or leg, oral contraceptives, major surgery, acute medical illness, obesity, or a
sedentary lifestyle. It is critical that athletic trainers recognize early signs and symptoms of
pulmonary embolism which warrants emergency management. Word Count: 316
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Introduction:
Pulmonary embolism (PE) is a blood clot that blocks a lung artery creating damage to
that part of the lung and can lead to hypertension.1 PE can also cause lower oxygen levels in the
blood, damage other organs due to low blood supply, and even death. Pulmonary embolism is
generally caused from a blood clot formed in the vein of a leg and travels to the lungs.1
Pulmonary embolisms can be categorized as either chronic or acute.2 An acute pulmonary
embolism develops in a short period of time. They are either treated and dissolves away or result
in mortality.2 A chronic PE occurs, when an acute PE is unable to completely dissolve.2 There
are two subsets of acute PE that are categorized by the presence or absence of a major
predisposing factor, embolus mobility, the size, and the pulmonary involvement. These subsets
are submassive and massive.2 When the right ventricular dysfunctions without hemodynamic
instability, which is identified through an electrocardiography. If several submassive pulmonary
emboli go undiagnosed, they can lead to a massive pulmonary embolism. A massive PE occurs
when blood pressure decreases more than 40 mm Hg for longer than 15 minutes, systolic blood
pressure less than 90 mm Hg, and pulmonary vasculature obstruction of more than 50 percent.2
Knowing what kind of pulmonary embolism the individual had can help health care
professionals monitor vital signs and symptoms and reduce the risk of the individual getting
more PE in the future.
PE is commonly found in individuals who have had surgery, are generally unhealthy, or
are elderly.1 The majority of these patients tend to recover. In 25% of people with PE, their first
symptom is sudden death.3,4 Approximately one third of the patients that do recover tend to have
recurrent pulmonary emboli within ten years after their primary embolism.3 In a young, healthy
population, factors that increase the risk of developing pulmonary embolism are cancer, fractures
2

of the hip or leg, oral contraceptives, major surgery, acute medical illness, obesity, or a sedentary
lifestyle. There have only been a few documented cases of competitive athletes sustaining a
pulmonary embolism.5 The occurrence of PE is often times due to the clotting protein mutation
some individuals have.
Factor V is a clotting protein found in the body.6 There are many anti-clotting proteins
that help to break the factor V, to help it from forming clots where they are not needed. Factor V
Leiden is a mutation that is a risk factor for venous thromboembolism, because it makes it harder
for the anticlotting proteins to break up the factor V.6 Most people with the mutation never
develop abnormal blood clots. However, some develop blood clots that can lead to long-term
health problems or become life-threatening. Although both men and women can have factor V
Leiden, women have an increased tendency to develop blood clots while pregnant or taking
hormone estrogen. The majority of people who have factor V Leiden never know because they
never exhibit any signs or symptoms.6 A blood clot may be the first indication of factor V
Leiden.6 Anticoagulants are a common medication for individuals who have factor V Leiden and
have developed blood clots.
CASE REPORT
A 19-year-old female National Collegiate Athletic Association Division I soccer player
(goalie) presented in the athletic training clinic, during pre-season with soreness and redness over
her left distal adductors reporting that she had been cleated during a camp she had coached at.
The athlete had equal strength, but side to side movement was painful. She was tender to palpate
over her distal adductors. Medical history revealed that the athlete was taking oral contraceptive
pills daily, had no recent travel, no recent long car trips, was not a smoker, and had no family
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history of cardiac conditions or blood clots. The initial assessment was adductor tendinitis and
she was treated conservatively. Over the next few days, many therapies were attempted:
corrective exercises, Graston technique, massage, dry needling, and myofascial release.
Myofascial release was the only therapy that provided any relief of the pain, besides rest.
Subsequently, the area became hot and red for a few days. During this time, the athlete was still
removed from participation and was icing the area that was hot and red area. Eventually signs
and symptoms resolved and the athlete returned to full participation. The athlete mentioned later
that she had felt intense pain with certain movements during practices that would bother her. She
always felt that she could work through this pain.
A few weeks later, the athlete went in one morning to the health center on campus. She
was having right sided chest pain and was in obvious discomfort. The day before the athlete
reported having the same pain that started in her upper right chest, worked its way into the lower
right chest along her ribs. The athlete took 800 mg of ibuprofen the night before with no relief.
The exam reported the athlete’s vital signs were all within normal limits, her lungs were clear to
auscultation with good air movement, there were no rales or wheezing. The athlete was nontender to palpate along lower right ribcage, no pain reproduced with palpation, her abdomen was
soft, not distended, and her upper right quadrant was non-tender to palpate.
The physician at the campus health center gave a 60 mg IM injection of toradol which
offered no relief to the athlete. A chest x-ray showed early signs of pneumonia. A D-dimer was
ordered as well, because the symptoms were not equivalent with pneumonia symptoms. A Ddimer or Fibrin Degradation Fragment is a lab test that assists in ruling out deep vein thrombosis,
pulmonary embolism, and stroke.7 It may be ordered when the patient presents with sudden
shortness of breath, labored breathing, coughing, lung-related chest pain, and/or a rapid heart
4

rate.7 A positive D-dimer test indicates abnormally high levels of fibrin degradation products in
the blood.7 The findings were inconclusive that it was truly a pulmonary embolism and the
athlete was referred to the emergency department for an evaluation at a hospital in town.
In the emergency department, the athlete was diagnosed with acute pulmonary embolism
on the right side. She was given oxycodone-acetaminophen for pain and XAREL(rivaroxaban)
twice daily for 21 days. The athlete was instructed to return to the emergency room if she
produced a fever, cough, bloody cough, worsening chest pain, or difficulty breathing. The athlete
was informed to remain on anticoagulants for three months and removed from practices.
After three months, the athlete went back to the hospital for a CT Chest Angiography.
The CT showed resolution to the pulmonary thromboembolic disease and no evidence of any
new pulmonary emboli. The athlete was informed that she could return to full participation
which included running, lifting, and soccer practices. A month later at a follow up appointment
at the hospital, the athlete had additional blood work performed which determined that she had a
factor V Leiden mutation on both alleles. The factor V Leiden mutation is a risk factor for
venous thromboembolism. Because factor V Leiden mutation increasing her chance of a blood
contact after possibly getting hit, the athlete was forced to end her soccer career early. However,
the athlete is still leads an active lifestyle with basic running and weightlifting.
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Introduction:
Pulmonary embolism (PE) is a blood clot that blocks a lung artery creating damage to the
lung and can lead to hypertension.1 PE can also cause lower oxygen levels in the blood, damage
other organs due to low blood supply, and death. Pulmonary embolism is generally caused from
a blood clot formed in the vein of a leg and travels to the lungs.1
Pulmonary embolisms can be categorized as either chronic or acute.2 An acute pulmonary
embolism develops in a short period of time. They are either treated and dissolve away, or result
in mortality.2 A chronic PE occurs when an acute PE is unable to completely dissolve.2 There are
two subsets of acute PE that are categorized by the presence or absence of a major predisposing
factor, embolus mobility, size, and pulmonary involvement. These subsets are submassive and
massive.2 A submassive pulmonary embolism occurs acutely without system hypotension
(systolic blood pressure greater than 90 mm Hg), but with either myocardial necrosis
(disorganized breakdown of heart tissue) or right ventricular (RV) dysfunction without a change
in hemodynamic instability (abnormal or unstable blood pressure).2,3 This can only be identified
through electrocardiography.2 Myocardial necrosis occurs if the elevation of troponin I is greater
than 0.4 ng/mL or the elevation of troponin T is greater than 0.1 ng/mL.3 Troponin I and T are
specific and sensitive indicators of damage to the myocardium.4 Right ventricular dysfunction
presents in one of the following ways: right ventricle systolic dysfunction on echocardiography,
right ventricle dilation on a computerized tomography (CT scan), elevation of B-type natriuretic
peptide (BNP) greater than 90 pg/mL, elevation of N-terminal pro-BNP (greater than 500
pg/mL), or electrocardiographic changes (new complete or incomplete right bundle-branch
block, anteroseptal ST elevation or depression, or anteroseptal T-wave inversion).3 All are
markers that are proven to be useful in diagnosing cardiovascular disorders.
8

If several submassive pulmonary emboli go undiagnosed, they can lead to a massive
pulmonary embolism. A massive PE occurs when blood pressure decreases more than 40 mm Hg
for longer than 15 minutes, systolic blood pressure less than 90 mm Hg, pulmonary vasculature
obstruction of more than 50 percent, or requires inotropic support (medicines that change the
force of the heart's contractions) not due to a cause other than a pulmonary embolism
(arrhythmia, hypovolemia, sepsis, left ventricular dysfunction, pulselessness, or persistent
profound bradycardia (heart rate less than 40 bpm with signs of shock).2,3 Knowing the type of
pulmonary embolism, the individual can help health care professionals monitor vital signs and
symptoms and reduce the risk of recurring PE.

Pulmonary embolism is commonly found in individuals who have had surgery, are
generally unhealthy, or are elderly.1 The majority of these patients tend to recover. In 25% of
people with PE, their first symptom is sudden death.5,6 Approximately one third of the patients
that do recover tend to have recurrent pulmonary emboli within ten years after their primary
embolism.5 In a young, healthy population, factors that increase the risk of developing
pulmonary embolism are cancer, fractures of the hip or leg, oral contraceptives, major surgery,
acute medical illness, obesity, or a sedentary lifestyle. There has only been one documented case
of a collegiate athlete sustaining a pulmonary embolism.7 The occurrence of PE is often times
due to the clotting protein mutation some individuals possess.
Factor V is a clotting protein found in the body.8 There are many anti-clotting proteins
that help to break the factor V, to help it from forming clots where they are not needed. Factor V
Leiden is a mutation that is a risk factor for venous thromboembolism because it makes it harder
for the anticlotting proteins to break up the factor V.8 Most people with the mutation never
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develop abnormal blood clots. However, some develop blood clots that can lead to long-term
health problems or become life-threatening. Although both men and women can have factor V
Leiden, women have an increased tendency to develop blood clots while pregnant or taking the
hormone estrogen. Factor V Leiden allele is present in about five percent of Caucasian
individuals, nearly absent in Africans, Asians, and races with Asian ancestry such as
Amerindians, Eskimos, and Polynesians.9 It is present in eighteen percent of Caucasian patients
with venous thrombosis. Conversely, factor V Leiden is usually not found in non-Caucasian
thrombotic patients.9 The majority of people who have this mutation never know because they
never exhibit any signs or symptoms.8 A blood clot may be the first indication of factor V
Leiden.8 Anticoagulants are a common medication for individuals who have factor V Leiden
mutation and have developed blood clots.
Case Report:
A 19-year-old female National Collegiate Athletic Association Division I soccer player
(goalie) presented in the athletic training clinic with soreness and redness over her left distal
adductors being cleated during a camp. The athlete had equal strength, but side to side movement
was painful. She was tender to palpate over her distal adductors. Medical history revealed that
the athlete was taking oral contraceptive pill Larin Fe daily, had no recent travel, no recent long
car trips, was not a smoker, and had no family history of cardiac conditions or blood clots. The
initial assessment was adductor tendinitis. She was treated conservatively. Over the next few
days, many therapies were attempted: corrective exercises, Graston technique, massage, dry
needling, and myofascial release. Myofascial release was the only therapy that provided any
relief of the pain, besides rest. Subsequently, the area became hot and red for a few days. During
this time, the athlete was still removed from participation and was icing the hot and red area.
10

Eventually, signs and symptoms resolved and the athlete returned to full participation. The
athlete mentioned later she had felt a bothersome, intense pain with certain movements during
practices. She always felt she could work through this pain.
A few weeks later, the athlete went to the health center on campus. She was having right
sided chest pain and was in obvious discomfort. The athlete reported having the same pain the
day before in her upper right chest, but it worked its way into the lower right chest along her ribs.
The athlete took 800 mg of ibuprofen the night before with no relief. The exam reported the
athlete’s vital signs were all within normal limits, her lungs were clear to auscultation with good
air movement, and there were no rales or wheezing. The athlete was non-tender to palpate along
lower right ribcage, no pain reproduced with palpation, her abdomen was soft, not distended, and
her upper right quadrant was non-tender to palpate.
The physician at the campus health center gave a 60 mg
IM injection of toradol which offered no relief to the athlete. A
chest x-ray showed early signs of pneumonia, shown in Figure
1. A D-dimer was ordered as well because the symptoms were
not equivalent with pneumonia symptoms. A D-dimer or Fibrin
Degradation Fragment is a lab test that assists in ruling out deep
vein thrombosis, pulmonary embolism, and stroke.10 It may be
ordered when the patient presents with sudden shortness of

Figure 1. Vague right lower lobe
parenchymal opacity

breath, labored breathing, coughing, lung-related chest pain,
and/or a rapid heart rate.10 A positive D-dimer test indicates abnormally high levels of fibrin
degradation products in the blood.10 The findings were inconclusive for pulmonary embolism
and the athlete was referred to the emergency department for an evaluation at a local hospital.
11

In the emergency department, the athlete was diagnosed
with acute pulmonary embolism on the right side. She was given
oxycodone-acetaminophen for pain and XAREL (rivaroxaban)
twice daily for 21 days. The athlete was instructed to return to the
emergency room if she produced a fever, cough, bloody cough,
worsening chest pain, or difficulty breathing. Figure 2 illustrates
the computerized tomography (CT) scans that were performed that
show pulmonary embolism in both the right and left lungs.
Figure 2. Top- Emboli in the
left lower lobe and a filling
defect in the central right
lower lobe pulmonary artery
extending into all of the
subsegmental. BottomPeripheral infiltrate in the left
posterior basilar right lower
lobe

Because of the PE, the athlete was informed to remain on
anticoagulants for three months and was removed from practices.
After three months, the athlete went back to the hospital for
a CT Chest Angiography. The CT showed resolution to the
pulmonary thromboembolic disease and no evidence of any new
pulmonary emboli as shown in Figure 3. The athlete was informed

Figure 3. Mild residual
parenchymal opacity
peripherally in the right lung
base and interval resolution
bilateral pulmonary
thromembolitic disease

she could return to full participation which included running,
lifting, and soccer practices. A month later, at a follow up hospital
appointment, the athlete had additional blood work performed
which determined she had a factor V Leiden mutation on both

alleles. The factor V Leiden mutation is a risk factor for venous thromboembolism. Because
factor V Leiden mutation increases her chance of a blood clot after possibly getting hit, the
athlete was forced to end her soccer career early.
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To this day, the athlete still leads an active lifestyle with basic running and weightlifting.
The athlete has learned to be cautious and aware of how she is feeling while working out. She
stays active to promote good blood flow, but is unable to play any contact sports. Future
lifestyle considerations for this athlete now include taking precautions while traveling (baby
aspirin and compression socks), avoiding prescriptions or medications that contain estrogen, and
obtaining regular blood work if placed on blood thinners again or wants to start having children.
Discussion:
There are several documented cases of PE in young athletic populations. The first
pulmonary embolism case report was in 1979 in a high school wrestler.11 The athlete reported flu
like symptoms (fever, nausea, weakness, and myalgias) two days prior to a match.11 After the
match, he was having trouble breathing for 30 minutes. Four days later, he competed again, this
time being pinned; he became cyanotic and oxygen was administered.11 The next day his
physician found a heart murmur after he complained of left scapular pain.11 The doctor also
found that the gas pressure and pH in his heart were elevated enough that he needed heparin
therapy. With no resolve, the athlete underwent median sternotomy bypass and total
cardiopulmonary bypass.11 Emboli of unknown age were removed from both pulmonary arteries.
The athlete was discharged from the hospital and received warafin sodium therapy.11 The athlete
did fully recover, but it is not documented if he continued to play sports. In 2007, a high school
male soccer player with no apparent risk factors had a sudden onset of dyspnea with no
discernable cause.12 This athlete had an elevated D-dimer, but all lab results were within normal
limits.12 The athlete had recurrent pulmonary emboli. The athlete was treated with the placement
of a Greenfield inferior vena cava filter (prevent life-threatening pulmonary emboli). Two and a
half years later, the athlete subsequently discontinued all anticoagulation therapy and remains
13

asymptomatic. It is not documented if the athlete continued to participate in contact sports. The
last documented case of a pulmonary embolism in a high school athlete occurred in 2015.13 The
athlete had exertional dyspnea for a year and a half. She was diagnosed with a massive PE.13 In
2009, the first collegiate athlete with PE was documented.7 She was a gymnast with no previous
history or family history of pulmonary or cardiac conditions and she presented with upper right
and left quadrant pain.7 Her symptoms became so bad that, in less than five minutes, she would
experience presyncope. Presyncope is a state consisting of lightheadedness, muscular weakness,
blurred vision, and feeling faint. Because of these feelings she decided to go to a clinic. After
further evaluation, she was referred to the team physician who referred her to the emergency
room.7 She had an elevated D-dimer and all other blood tests were within normal limits. After a
course of blood thinners, the athlete was allowed to return to full participation.
Young, healthy athletes often times will not present with the classic symptoms associated
with PE. Early diagnosis of pulmonary emboli is critical, but vague symptoms make it difficult
to recognize. A differential diagnosis such as musculoskeletal pain, pleuritic, pericarditis,
hyperventilation, and lung trauma should be considered when a patient presenting with
abdominal pain, fever, productive cough, new onset of atrial fibrillation, hyperventilation,
tachycardia, bradycardia, course breath sounds, dyspnea, or tachypnea (common symptoms
found with pulmonary embolism).7,11,14 Athletes rarely sustain a PE, but delayed treatment could
be fatal.
Nonetheless, health care providers should understand and screen for inherited conditions,
which, when coupled with oral contraceptive use, can create a high-risk scenario for pulmonary
emboli. Screening for factor V Leiden mutation in individuals with no history of blood clots is
currently recommended for individuals who are relatives of patients identified as carriers.9 There
14

is no data available to justify screening all athletes for the mutation; however, health care
providers should take into consideration that oral contraceptives, pregnancy, or high-risk surgery
increase the chance of pulmonary emboli.9
Our soccer athlete may be the first athlete to sustain a career ending pulmonary
embolism. Furthermore, she is the only case that presented with a positive factor V Leiden
mutation and a non-elevated D-dimer. The athlete did not have any cardiac or pulmonary history,
therefore there was no need for blood testing prior to this event. Therefore, as healthcare
providers, we should be asking questions about family history or previous history of pulmonary
embolism. Athletes who answer yes should receive further screening because they may have a
higher likelihood of pulmonary embolism.
Conclusion:
Pulmonary embolism is not commonly found in athletes; few cases have been reported.
In this case, when the adductor injury became red and hot, referral was warranted. Although,
common symptoms of deep vein thrombosis (DVT) are swelling, warm skin, red or discolored
skin, or tired legs, DVTs are not commonly found in the adductors.15 Because the initial
evaluation was diagnosed as adductor tendinitis, the possible deep vein thrombosis was missed.
Making sure that health care professionals know the signs and symptoms of DVT and PE is
important in making sure athletes are seeking proper medical treatment. If an athlete does
complain of chest pain, difficulty breathing, or differences in normal heart beats, they should be
referred to the team physician or emergency room. An early diagnosis of these symptoms is key
for appropriate treatment and decreases the likelihood of mortality. Health care providers should
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ensure proper screening and follow-up treatment, as well as monitor diagnosed athletes with PE
to facilitate compliance.7
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